Elanco Animal Health (ELAN) Receivables (2017 - 2026)
Elanco Animal Health (ELAN) posted Receivables of $1.2 billion for Q1 2026, up 22.77% sequentially from $940.0 million in Q4 2025, and up 8.87% YoY from $1.1 billion in Q1 2025.
Elanco Animal Health (ELAN) Receivables (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Receivables for 10 years, with the latest figure at $1.2 billion in Q1 2026.
- Quarterly Receivables rose 8.87% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 8.87% YoY) and the FY2025 annual result came in at $940.0 million, up 6.09% from the prior year.
- Receivables grew to $1.2 billion in Q1 2026 per ELAN's latest filing, from $940.0 million in the prior quarter.
- Over five years, Receivables peaked at $1.3 billion in Q1 2023 and troughed at $886.0 million in Q4 2024.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2023 and 2024: Receivables increased 10.41% in 2023, then decreased 20.35% in 2024.
- Over 5 years, Receivables stood at $1.0 billion in 2022, then advanced by 0.8% to $1.0 billion in 2023, then dropped by 12.28% to $886.0 million in 2024, then gained by 6.09% to $940.0 million in 2025, then gained by 22.77% to $1.2 billion in 2026.
- According to Business Quant data, Receivables over the past three periods registered $1.2 billion, $940.0 million, and $975.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 1.08 Bn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 456.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Bn |
| Mar 31, 2026 | 1.15 Bn |
| Dec 31, 2025 | 940.00 Mn |
| Sep 30, 2025 | 975.00 Mn |
| Jun 30, 2025 | 1.10 Bn |
| Mar 31, 2025 | 1.06 Bn |
| Dec 31, 2024 | 886.00 Mn |
| Sep 30, 2024 | 904.00 Mn |
| Jun 30, 2024 | 1.08 Bn |
| Mar 31, 2024 | 1.08 Bn |
| Dec 31, 2023 | 1.01 Bn |
| Sep 30, 2023 | 1.14 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 1.26 Bn |
| Dec 31, 2022 | 1.00 Bn |
| Sep 30, 2022 | 1.03 Bn |
| Jun 30, 2022 | 1.13 Bn |
| Mar 31, 2022 | 1.19 Bn |
| Dec 31, 2021 | 1.03 Bn |
| Sep 30, 2021 | 1.08 Bn |